VR Eye Movement Monitor Helps Assess Concussion
|
By HospiMedica International staff writers Posted on 21 Oct 2021 |
|
Image: The Eye-Sync device with the Samsung Gear VR headset (Photo courtesy of SyncThink)
A virtual reality (VR) eye-tracking platform provides objective measurements to aid in diagnosis of mild traumatic brain injury (TBI).
The SyncThink (Holliston, MA, USA) Eye-Sync device consists of a VR headset with infrared (IR) cameras that track eye movement, helping clinicians to objectively evaluate visual impairments, monitor recovery, and support the rehabilitation of ocular-motor and ocular-vestibular deficits. Eye-Sync includes smooth pursuit (clockwise and anti-clockwise), vestibule-ocular reflex (VOR), and saccade (horizontal and vertical) based 60-second assessments that objectively measure eye movements, and also offers multiple modalities to train dynamic vision.
Following assessment, the VR headset connects wirelessly to a tablet device, where results can be viewed within sixty seconds. Eye-Sync is available with the Pico (San Francisco, CA, USA) Neo 2 Eye or the Samsung (Seoul, Korea) Gear Bluetooth enabled VR headsets; a Samsung S5e android tablet; a protective carrying case; paradigms for patient assessment, therapy, and training; electronic medical record (EMR) integration and rest API access; and secure, HIPAA compliant data storage.
“SyncThink develops revolutionary eye-tracking technology and analytics, in a virtual reality environment. With millions of concussions occurring each year, the need for a rapid, mobile and most importantly, objective metric for impairment and recovery is clear,” said Laura Yecies, CEO of SyncThink. “SyncThink remains dedicated to developing technology to allow everyone from athletes to patients to objectively monitor and improve their brain health and performance.”
The technology is designed to measure variance in synchronization abilities, or how much error is produced when interacting with visual cues. Each assessment is designed to identify the quality of performance with respect to synchronizing eye movement with a moving object, or by examining gaze fixation. Concussion, attention deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), and other neurodegenerative disorders all have unique synchronization deficits, providing a biomarker of impairment and/or pathology.
Related Links:
SyncThink
Pico
Samsung
The SyncThink (Holliston, MA, USA) Eye-Sync device consists of a VR headset with infrared (IR) cameras that track eye movement, helping clinicians to objectively evaluate visual impairments, monitor recovery, and support the rehabilitation of ocular-motor and ocular-vestibular deficits. Eye-Sync includes smooth pursuit (clockwise and anti-clockwise), vestibule-ocular reflex (VOR), and saccade (horizontal and vertical) based 60-second assessments that objectively measure eye movements, and also offers multiple modalities to train dynamic vision.
Following assessment, the VR headset connects wirelessly to a tablet device, where results can be viewed within sixty seconds. Eye-Sync is available with the Pico (San Francisco, CA, USA) Neo 2 Eye or the Samsung (Seoul, Korea) Gear Bluetooth enabled VR headsets; a Samsung S5e android tablet; a protective carrying case; paradigms for patient assessment, therapy, and training; electronic medical record (EMR) integration and rest API access; and secure, HIPAA compliant data storage.
“SyncThink develops revolutionary eye-tracking technology and analytics, in a virtual reality environment. With millions of concussions occurring each year, the need for a rapid, mobile and most importantly, objective metric for impairment and recovery is clear,” said Laura Yecies, CEO of SyncThink. “SyncThink remains dedicated to developing technology to allow everyone from athletes to patients to objectively monitor and improve their brain health and performance.”
The technology is designed to measure variance in synchronization abilities, or how much error is produced when interacting with visual cues. Each assessment is designed to identify the quality of performance with respect to synchronizing eye movement with a moving object, or by examining gaze fixation. Concussion, attention deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), and other neurodegenerative disorders all have unique synchronization deficits, providing a biomarker of impairment and/or pathology.
Related Links:
SyncThink
Pico
Samsung
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gas Analyzer
GE SAM
New
Fetal Monitor
BT-380
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
